Flowchart Overview
 
23
ALLIANCE-A041703 Phase II OPEN TO ACCRUAL
ALLIANCE-MM1MDS-A01 Phase II OPEN TO ACCRUAL
CTN-2203 Phase III OPEN TO ACCRUAL
DAIICHI-SANKYO-DS3201-343 Phase I OPEN TO ACCRUAL
DAIICHI-SANKYO-DS3939-077 Phase I/II OPEN TO ACCRUAL
ECOG-EA4232 Phase III OPEN TO ACCRUAL
ECOG-EA7222 Phase III OPEN TO ACCRUAL
IIT-AKHTAR-CILTA-TALQ Phase I OPEN TO ACCRUAL
INCYTE-INCA035784-101 Phase I OPEN TO ACCRUAL
INNOCARE-ICP-CL-01205 Phase I OPEN TO ACCRUAL
KURA-KO-MEN-015 Phase I OPEN TO ACCRUAL
KURA-KO-MEN-017 Phase III OPEN TO ACCRUAL
MERCK-MK2140-011-00 Phase II OPEN TO ACCRUAL
MODERNA-MRNA-2808-P101 Phase I/II OPEN TO ACCRUAL
NOVARTIS-CABL001A2001B Phase IV OPEN TO ACCRUAL *
NRG-CC013 Phase II OPEN TO ACCRUAL
NRG-HN006 Phase II/III OPEN TO ACCRUAL
NRG-HN010 Phase II OPEN TO ACCRUAL *
STEMLINE-MEN2312-01 Phase I OPEN TO ACCRUAL
SWOG-MM1OA-S03 Phase II OPEN TO ACCRUAL
SWOG-MM1YA-S01 Phase II OPEN TO ACCRUAL
TERREMOTO-TER-2013-C01 Phase I/II OPEN TO ACCRUAL
TEVA-TV56278-ONC-10203 Phase I OPEN TO ACCRUAL
1
2
2
3
1
1
2
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
NEOGENE-NT-175-201 Phase I OPEN TO ACCRUAL
2
4
1
8
CARIBOU-CAMMOUFLAGE-CB-011A-MM Phase I OPEN TO ACCRUAL
CELGENE-GC-LTFU-001 Phase II/III OPEN TO ACCRUAL
GRACELL-GC012F-CD19-BCMA-001 Phase I/II OPEN TO ACCRUAL
GSK-3377794-LTFU Phase I OPEN TO ACCRUAL
IIT-SHAH-IL7-IL15-CD20-19 Phase I/II OPEN TO ACCRUAL
JNJ-MY4002-CARTINUE-LTFU Phase IV OPEN TO ACCRUAL
NEOGENE-NT-112-301 Phase I OPEN TO ACCRUAL
NEOGENE-NT-175-201 Phase I OPEN TO ACCRUAL
1
NEOGENE-NT-112-301 Phase I OPEN TO ACCRUAL
1
2
1
3
1
3
1
4
3
2
1
3
1
2
1
2
1
1
NEOGENE-NT-112-301 Phase I OPEN TO ACCRUAL
1
2
1
2
4
2
3
2
1
4
1
3
1
2
3
1
1
1
4
6
2
1
4
NEOGENE-NT-175-201 Phase I OPEN TO ACCRUAL
NRG-CC013 Phase II OPEN TO ACCRUAL
NRG-HN006 Phase II/III OPEN TO ACCRUAL
NRG-HN010 Phase II OPEN TO ACCRUAL *
2
5
1
6
4
2
1
1
1
1
2
3
2
1
1
2
2
1
6
AZ-D516NC00001-TROPION-LUNG14 Phase III OPEN TO ACCRUAL *
BMS-CA2400009 Phase II OPEN TO ACCRUAL *
IIT-GORE-REDIRICT Phase II OPEN TO ACCRUAL
LILLY-J3M-MC-JZQH Phase III OPEN TO ACCRUAL *
NEOGENE-NT-112-301 Phase I OPEN TO ACCRUAL
SWOG-S2409-PRISM Phase II OPEN TO ACCRUAL
3
6
1
7
4
9
CARNABIOSCIENCES-C1763102 Phase I OPEN TO ACCRUAL
CTN-2203 Phase III OPEN TO ACCRUAL
DAIICHI-SANKYO-DS3201-343 Phase I OPEN TO ACCRUAL
DAIICHI-SANKYO-DS3939-077 Phase I/II OPEN TO ACCRUAL
ICHNOS-ISB-2001-101 Phase I OPEN TO ACCRUAL
IIT-GORE-REDIRICT Phase II OPEN TO ACCRUAL
STEMLINE-MEN2312-01 Phase I OPEN TO ACCRUAL
TERREMOTO-TER-2013-C01 Phase I/II OPEN TO ACCRUAL
TEVA-TV56278-ONC-10203 Phase I OPEN TO ACCRUAL
8
7
2
2
2
1
1
2
2
2
2
1
1
2
2
2
2
2
2
1
1
1
5
3
3
1
1
1
1
1
1
2
9
1
2
4
2
6
4
6
4
2
2
7
1
5
1
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
1
ALLIANCE-A151804 Phase N/A OPEN TO ACCRUAL
10
ALLIANCE-MM1MDS-A01 Phase II OPEN TO ACCRUAL
ECOG-EA4232 Phase III OPEN TO ACCRUAL
ICHNOS-ISB-2001-101 Phase I OPEN TO ACCRUAL
IIT-AKHTAR-CILTA-TALQ Phase I OPEN TO ACCRUAL
INCYTE-INCA035784-101 Phase I OPEN TO ACCRUAL
INNOCARE-ICP-CL-01205 Phase I OPEN TO ACCRUAL
MODERNA-MRNA-2808-P101 Phase I/II OPEN TO ACCRUAL
NOVARTIS-CABL001A2001B Phase IV OPEN TO ACCRUAL *
SWOG-MM1OA-S03 Phase II OPEN TO ACCRUAL
SWOG-MM1YA-S01 Phase II OPEN TO ACCRUAL
18
ALLIANCE-A041501-ALL Phase III OPEN TO ACCRUAL
ALLIANCE-MM1MDS-A01 Phase II OPEN TO ACCRUAL
CARNABIOSCIENCES-C1763102 Phase I OPEN TO ACCRUAL
CCTG-MM1YA-CTG01 Phase II OPEN TO ACCRUAL
CTN-2203 Phase III OPEN TO ACCRUAL
DISC-0974-102 Phase I/II OPEN TO ACCRUAL
ECOG-MM1OA-EA02 Phase II OPEN TO ACCRUAL
HJKC3-0003 Phase II OPEN TO ACCRUAL
IIT-SHAH-IL7-IL15-CD20-19 Phase I/II OPEN TO ACCRUAL
INCYTE-INCA035784-101 Phase I OPEN TO ACCRUAL
INNOCARE-ICP-CL-01205 Phase I OPEN TO ACCRUAL
JNJ-75276617ALE1001 Phase I/II OPEN TO ACCRUAL
KURA-KO-MEN-007 Phase I OPEN TO ACCRUAL
KURA-KO-MEN-008 Phase I OPEN TO ACCRUAL
NOVARTIS-CABL001A2001B Phase IV OPEN TO ACCRUAL *
SWOG-MM1OA-S03 Phase II OPEN TO ACCRUAL
SWOG-MM1YA-S01 Phase II OPEN TO ACCRUAL
UCHICAGO-IRB23-1681 Phase I OPEN TO ACCRUAL
3
2
1
1
9
4
6
1
2
2
2
1
4
2
2
2
11
ALLIANCE-A052101 Phase III OPEN TO ACCRUAL
CARNABIOSCIENCES-C1763102 Phase I OPEN TO ACCRUAL
CTN-2203 Phase III OPEN TO ACCRUAL
DFCI-22-702 Phase II OPEN TO ACCRUAL
ECOG-EA4232 Phase III OPEN TO ACCRUAL
IIT-SHAH-ELDERLY-DLBCL Phase II OPEN TO ACCRUAL
IIT-SHAH-IL7-IL15-CD20-19 Phase I/II OPEN TO ACCRUAL
MILTENYI-MB-CART2019-1-DLBCL Phase II OPEN TO ACCRUAL
NURIX-NX-5948-301 Phase I OPEN TO ACCRUAL
SWOG-S2114 Phase II OPEN TO ACCRUAL
SWOG-S2308 Phase III OPEN TO ACCRUAL
3
8
3
2
1
4
2
4
3
2
2
2
1
1
1
1
10
ALLIANCE-A062101 Phase I/II OPEN TO ACCRUAL
BEIGENE-BGB-11417-105 Phase I/II OPEN TO ACCRUAL
  CELGENE-GC-LTFU-001 Phase II/III OPEN TO ACCRUAL
EMN30-64007957MMY3003-MAJESTEC Phase III OPEN TO ACCRUAL
ICHNOS-ISB-2001-101 Phase I OPEN TO ACCRUAL
IIT-AKHTAR-CILTA-TALQ Phase I OPEN TO ACCRUAL
JNJ-MY4002-CARTINUE-LTFU Phase IV OPEN TO ACCRUAL
MODERNA-MRNA-2808-P101 Phase I/II OPEN TO ACCRUAL
SWOG-S2213 Phase III OPEN TO ACCRUAL
UAB-21107-MASTER-2-MM Phase II OPEN TO ACCRUAL
1
2
2
3
1
SWOG-MM1OA-S03 Phase II OPEN TO ACCRUAL
25
COG-AALL1732 Phase III OPEN TO ACCRUAL
COG-AALL1821 Phase II OPEN TO ACCRUAL
COG-AALL2131 Phase III OPEN TO ACCRUAL *
COG-AALL2321 Phase II OPEN TO ACCRUAL *
COG-AAML1831 Phase III OPEN TO ACCRUAL
COG-ACNS1821 Phase I/II OPEN TO ACCRUAL
COG-ACNS1833 Phase III OPEN TO ACCRUAL
COG-ACNS2031 Phase III OPEN TO ACCRUAL
COG-AGCT1531 Phase III OPEN TO ACCRUAL
COG-AHOD2131 Phase III OPEN TO ACCRUAL
COG-ALLIANCE-AGCT1532-P3BEP Phase III OPEN TO ACCRUAL *
COG-ANBL1531 Phase III OPEN TO ACCRUAL
COG-AREN1921 Phase II OPEN TO ACCRUAL *
IIT-BURKE-VENETOCLAX-EPIGENETI Phase I OPEN TO ACCRUAL
MSKCC-23-278 Phase II OPEN TO ACCRUAL
NYMC-571 Phase II OPEN TO ACCRUAL *
NYMC-579 Phase II OPEN TO ACCRUAL *
NYMC-580 Phase II OPEN TO ACCRUAL *
NYMC-581 Phase II OPEN TO ACCRUAL
NYMC-600 Phase II OPEN TO ACCRUAL *
PBMTC-ONC1401 Phase II OPEN TO ACCRUAL
P-HEMONC-CUIMC-23-040 Phase II OPEN TO ACCRUAL *
PTCTC-ONC2301 Phase I/II OPEN TO ACCRUAL *
SPOC-2012-001 Phase I OPEN TO ACCRUAL
SYMBIO-BCV-PA02 Phase III OPEN TO ACCRUAL *
5
IIT-MOSKOP-MABD Phase N/A OPEN TO ACCRUAL
MSKCC-23-278 Phase II OPEN TO ACCRUAL
PBMTC-ONC1401 Phase II OPEN TO ACCRUAL
P-HEMONC-CUIMC-23-040 Phase II OPEN TO ACCRUAL *
PTCTC-ONC2301 Phase I/II OPEN TO ACCRUAL *
3
COG-ACNS1821 Phase I/II OPEN TO ACCRUAL
COG-ACNS1833 Phase III OPEN TO ACCRUAL
COG-ACNS2031 Phase III OPEN TO ACCRUAL
8
COG-AALL1821 Phase II OPEN TO ACCRUAL
COG-AREN1921 Phase II OPEN TO ACCRUAL *
IIT-BURKE-VENETOCLAX-EPIGENETI Phase I OPEN TO ACCRUAL
MSKCC-23-278 Phase II OPEN TO ACCRUAL
PBMTC-ONC1401 Phase II OPEN TO ACCRUAL
P-HEMONC-CUIMC-23-040 Phase II OPEN TO ACCRUAL *
PTCTC-ONC2301 Phase I/II OPEN TO ACCRUAL *
SPOC-2012-001 Phase I OPEN TO ACCRUAL
6
NYMC-571 Phase II OPEN TO ACCRUAL *
NYMC-579 Phase II OPEN TO ACCRUAL *
NYMC-580 Phase II OPEN TO ACCRUAL *
NYMC-581 Phase II OPEN TO ACCRUAL
NYMC-600 Phase II OPEN TO ACCRUAL *
SYMBIO-BCV-PA02 Phase III OPEN TO ACCRUAL *
8
COG-AALL1732 Phase III OPEN TO ACCRUAL
COG-AALL1821 Phase II OPEN TO ACCRUAL
COG-AALL2131 Phase III OPEN TO ACCRUAL *
COG-AALL2321 Phase II OPEN TO ACCRUAL *
COG-AAML1831 Phase III OPEN TO ACCRUAL
IIT-BURKE-VENETOCLAX-EPIGENETI Phase I OPEN TO ACCRUAL
PBMTC-ONC1401 Phase II OPEN TO ACCRUAL
PTCTC-ONC2301 Phase I/II OPEN TO ACCRUAL *
3
COG-AALL1732 Phase III OPEN TO ACCRUAL
COG-AHOD2131 Phase III OPEN TO ACCRUAL
PTCTC-ONC2301 Phase I/II OPEN TO ACCRUAL *
3
MSKCC-23-278 Phase II OPEN TO ACCRUAL
P-HEMONC-CUIMC-23-040 Phase II OPEN TO ACCRUAL *
X4P-001-110 Phase III OPEN TO ACCRUAL *
3
COG-AALL2131 Phase III OPEN TO ACCRUAL *
COG-AALL2321 Phase II OPEN TO ACCRUAL *
COG-ACNS1833 Phase III OPEN TO ACCRUAL
5
COG-AGCT1531 Phase III OPEN TO ACCRUAL
COG-ALLIANCE-AGCT1532-P3BEP Phase III OPEN TO ACCRUAL *
COG-ANBL1531 Phase III OPEN TO ACCRUAL
COG-AREN1921 Phase II OPEN TO ACCRUAL *
SPOC-2012-001 Phase I OPEN TO ACCRUAL